论文部分内容阅读
目的探讨沐舒坦治疗胎儿窘迫的疗效。方法在我院分娩的早产产妇204例根据治疗药物选择的不同分为治疗组102例与对照组102例,对照组应用地塞米松治疗,治疗组应用沐舒坦治疗。结果所有产妇都分娩出了胎儿,无产妇与胎儿死亡情况。不过治疗组的胎儿窘迫发生率1(0.98%)明显少于对照组(7.84%)(P<0.05)。治疗组的不良反应稍多于对照组,但是没有1例因不能耐受而退出治疗,两组不良反应情况对比无明显差异(P>0.05)。结论产前使用沐舒坦能降低胎儿窘迫的发生率,也相对安全,值得在临床上推广应用。
Objective To investigate the efficacy of mucosolvan in the treatment of fetal distress. Methods A total of 204 preterm labor women delivered in our hospital were divided into treatment group (102 cases) and control group (102 cases). Dexamethasone was used as the control group and Mucosolvan was used as the control group. Results All mothers gave birth to the fetus without maternal and fetal deaths. However, the incidence of fetal distress in treatment group was significantly lower than that in control group (0.98% vs 7.84%, P <0.05). Adverse reactions in the treatment group slightly more than the control group, but no one due to intolerance and exit treatment, no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion Preoperative use of mucosolvan can reduce the incidence of fetal distress, but also relatively safe, it is worth in the clinical application.